Gujarat Themis Biosyn Ltd

BSE : GUJTHEMIS14 Feb 2025
Pharmaceuticals
-11.35 (-4.36%)
Lowest Today
Highest Today
Today’s Open
Prev. Close
52 Week High
52 Week Low
To Invest in Gujarat Themis Biosyn Ltd
Gujarat Themis Biosyn Ltd
Pharmaceuticals
BSE : GUJTHEMIS14 Feb 2025
-11.35 (-4.36%)
OverviewFundamentals
1D
1M
6M
1Y
5Y
All

Gujarat Themis Biosyn Ltd - Share Price & Details

Traded Volume
Market Cap(Cr)
Avg Traded Price
1 Year return
13.32%
Upper Circuit
Lower Circuit
P/E TTM
51.48
P/B Ratio
12.15
Traded Value(Cr)
0.00
EPS TTM
4.84
Book value
Dividend
0.27%

Invest in Gujarat Themis Biosyn Ltd at ZERO Brokerage for 30 days

Price Performance

-13.59 %
1 Wk
-20.13 %
1 M
-15.28 %
3 M
13.32 %
1 Y
-21.38 %
YTD

Traded Volume Movement

Technical Details

Support 3
0
Support 2
0
Support 1
0
Pivot Point :
0
Resistance 1
0
Resistance 2
0
Resistance 3
0

Peer Comparison

Scrip NamePriceDaily ChangeM.Cap (Cr)1 Year Returns %P/E (TTM)PB Ratio
Gujarat Themis Biosyn Ltd
₹249.15(-11.35/-4.36%)
249.15-11.352,714.8713.3251.4812.15
Astrazeneca Pharma India Ltd
₹7,096.35(-314.25/-4.24%)
7,096.35-314.2517,740.8832.10105.8426.11
Bliss GVS Pharma Ltd
₹132.25(-5.05/-3.68%)
132.25-5.051,393.5211.6017.181.36
Amrutanjan Health Care Ltd
₹612.45(-25.00/-3.92%)
612.45-25.001,770.63-4.9135.905.95
Abbott India Ltd
₹27,859.05(-511.85/-1.80%)
27,859.05-511.8559,200.48-4.9244.3616.81
Ambalal Sarabhai Enterprises Ltd
₹48.41(-0.97/-1.96%)
48.41-0.97370.98-18.4142.108.23

About Gujarat Themis Biosyn Ltd

Gujarat Themis Biosyn Ltd is in the Pharmaceuticals sector, having a market capitalization of Rs. 2714.87 crores. It has reported a sales of Rs. 39.52 crores and a net profit of Rs. 12.97 crores for the quarter ended December 2018. The company management includes Dinesh S Patel, Dinesh S Patel,Sachin D Patel,VIJAY GOPI KISHAN AGARWAL,Kirandeep Madan,Siddharth Y Kusumgar,RAHUL DWARAKA SONI,Hitesh Dharmasinh Gajaria (Gujarat Themis Biosyn Ltd) among others.
Chairman
Dinesh S Patel
Registered office
69/C GIDC Industrial Estate,Valsad Dist,VAPI,Gujarat,396195
FAX :91-260-2400639
Background
Incorporation Year1981
Face Value₹1
Market Lot1

Latest News

Trump, Tariffs & Trades: Sensex ends in red for 8th straight day

India's equity indices fell for the eighth straight day, the longest losing streak in two years, due to concerns over Donald Trump's trade tariff proposals, with Nifty and Sensex declining 0.44% and 0.26% respectively. Analysts believe the market is oversold and a bounce back may depend on a slowdown in foreign fund selling.
15 Feb 2025 | 10:55 AM

Trump, Tariffs & Trades: Sensex ends in red for 8th straight day

India's equity indices fell for the eighth straight day, the longest losing streak in two years, due to concerns over Donald Trump's trade tariff proposals, with Nifty and Sensex declining 0.44% and 0.26% respectively. Analysts believe the market is oversold and a bounce back may depend on a slowdown in foreign fund selling.
15 Feb 2025 | 10:55 AM

Easy Trip Planners Q3 Profit Drops 26%, Hotel Bookings Surge 172%

Easy Trip Planners Ltd (ETPL) reported a 26.3% year-on-year decline in net profit to ₹33.6 crore for Q3 FY25, with revenue from operations down 6.5% to ₹150.5 crore. EBITDA fell 21.8% to ₹47.7 crore, with a 31.7% margin. Despite this, gross booking revenue for 9M FY25 was ₹6,499 crore, driven by strong growth in hotel and other bookings.
15 Feb 2025 | 04:26 PM

Glenmark Pharmaceuticals Q3 results 2025 on 15 Feb, 2025

Glenmark Pharmaceuticals Q3 Results 2025: Glenmark Pharmaceuticals declared their Q3 results on 14 Feb, 2025, revealing a significant increase in topline by 35.14%, with profit reaching ₹347.96 Cr. This marks a remarkable turnaround from the loss of ₹351.37 Cr reported during the same period in the previous fiscal year.
15 Feb 2025 | 02:09 PM

Sakuma Exports Q3 Results 2025 on 15 Feb, 2025

Q3 Results 2025: Sakuma Exports declared their Q3 results on 14 Feb, 2025, revealing a significant decline in financial performance. The company’s topline decreased by 38.68% year-over-year (YoY), with profit plummeting by 47.75% YoY. For Q3, Sakuma reported a profit of ₹3.37 crore and revenue of ₹477.73 crore.
15 Feb 2025 | 02:06 PM

How to buy Gujarat Themis Biosyn Ltd shares on nse?

To buy Gujarat Themis Biosyn Ltd shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the Gujarat Themis Biosyn Ltd share price today?

The Gujarat Themis Biosyn Ltd shares price on nse is Rs.249.15 today.

What is the market cap of Gujarat Themis Biosyn Ltd shares on BSE ?

The company has a market capitalization of Rs.2714.87Cr

What is the PE & PB ratio of Gujarat Themis Biosyn Ltd shares ?

PE is 51.48 and PB is 12.15

What is the 52 Week High and Low of Gujarat Themis Biosyn Ltd shares?

Gujarat Themis Biosyn Ltd stock price high: Rs.390 Gujarat Themis Biosyn Ltd stock price low: Rs.211.33
Click here to see your activities